Prostate Pathology: Prostate Carcinoma, variants and Gleason Grading (Part 1)

Similar documents
S1.04 Principal clinician. G1.01 Comments. G2.01 *Specimen dimensions (prostate) S2.02 *Seminal vesicles

They Do Look Alike : Mimics of Prostate Cancer in Biopsy Samples

3/28/2017. Disclosure of Relevant Financial Relationships. GU Evening Subspecialty Case Conference. Differential Diagnosis:

PROSTATIC ADENOCARCINOMA: DIAGNOSTIC CRITERIA AND IMPORTANT MIMICKERS PROSTATIC ADENOCARCINOMA: DIAGNOSTIC CRITERIA

5/21/2018. Difficulty in Underdiagnosing Prostate Cancer. Diagnosis of Prostate Cancer. Evaluation of Prostate Cancer and Atypical on Needle Biopsy

Grading Prostate Cancer: Recent Changes and Refinements

ACCME/Disclosures. Cribriform Lesions of the Prostate. Case

Prostate Cancer Grading, Staging and Reporting: An Update Cristina Magi-Galluzzi, MD, PhD

Gross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of

Diagnosis, pathology and prognosis including variant pathology

PSA. HMCK, p63, Racemase. HMCK, p63, Racemase

Prostate cancer grading: a decade after the 2005 modified system

Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance

Synonyms. Nephrogenic metaplasia Mesonephric adenoma

S1.04 PRINCIPAL CLINICIAN G1.01 COMMENTS S2.01 SPECIMEN LABELLED AS G2.01 *SPECIMEN DIMENSIONS (PROSTATE) S2.03 *SEMINAL VESICLES

Macro- and microacinar proliferations of the prostate

Immunohistochemistry in prostate pathology: Recent Advances

Prostate cancer ~ diagnosis and impact of pathology on prognosis ESMO 2017

Pathology of the Prostate. PathoBasic Tatjana Vlajnic

ARTHUR PURDY STOUT SOCIETY COMPANION MEETING: DIFFICULT NEW DIFFERENTIAL DIAGNOSES IN PROSTATE PATHOLOGY. Jonathan I. Epstein.

INTRADUCTAL LESIONS OF THE PROSTATE. Jonathan I. Epstein

2016 WHO CLASSIFICATION OF TUMOURS OF THE PROSTATE. Peter A. Humphrey, MD, PhD Yale University School of Medicine New Haven, CT

Update on Reporting Prostate Cancer Pathology

Procedures Needle Biopsy Transurethral Prostatic Resection Suprapubic or Retropubic Enucleation (Subtotal Prostatectomy) Radical Prostatectomy

Gleason Scoring System 2017 JASREMAN DHILLON, MD ASSOCIATE PROFESSOR, DEPARTMENT OF ANATOMIC PATHOLOGY, MOFFITT CANCER CENTER, TAMPA, FLORIDA

Uropathology January Jon Oxley

Some prostatic diseases

5/21/2018. Prostate Adenocarcinoma vs. Urothelial Carcinoma. Common Differential Diagnoses in Urological Pathology. Jonathan I.

Mody. AIS vs. Invasive Adenocarcinoma of the Cervix

Urinary Bladder: WHO Classification and AJCC Staging Update 2017

GOBLET CELL CARCINOID. Hanlin L. Wang, MD, PhD University of California Los Angeles

GOBLET CELL CARCINOID

3/23/2017. Significant Changes in Prostate Cancer Classification, Grading, Staging and Reporting. Disclosure of Relevant Financial Relationships

Prostate Immunohistochemistry. Literature Interpretation: Caveats. Must be aware of staining pattern of antibody in the relevant tissue

Demystifying Endometrial Hyperplasia

Objectives. Atypical Glandular Cells. Atypical Endocervical Cells. Reactive Endocervical Cells

Outline (1) Outline (2) Concepts in Prostate Pathology. Peculiarities of Prostate Cancer. Peculiarities of Prostate Cancer

Although current American Cancer Society guidelines

Prostate Overview Quiz

ISPUB.COM. Interpretation Of Prostatic Biopsies: A Review. A Chitale, S Khubchandani INTRODUCTION NON-NEOPLASTIC LESIONS GRADING: GLEASON'S SCORE

Protocol for the Examination of Specimens From Patients With Carcinoma of the Prostate Gland

Dissertation submitted in. Partial fulfilment of the regulations required for the award of M.D. DEGREE PATHOLOGY BRANCH III THE TAMILNADU

Unknown Slides Conference

Update on 2015 WHO Classification of Lung Adenocarcinoma 1/3/ Mayo Foundation for Medical Education and Research. All rights reserved.

Objective. Atypical/Atypia. Atypical Glandular Lesions of the Prostate 12/27/2011

05/07/2018. Types of challenges. Challenging cases in uterine pathology. Case 1 ` 65 year old female Post menopausal bleeding Uterine Polyp

CLINICAL SIGNIFICANCE OF BENIGN EPITHELIAL CHANGES

Prostatic ductal adenocarcinoma is a subtype of

International Society of Gynecological Pathologists Symposium 2007

Review Article Recent advances in prostate cancer pathology: Gleason grading and beyond

Normal Morphology. Anatomic Considerations. Normal Urothelial Histology and Cytology

Prostate Biopsy Interpretation: An Illustrated Guide

Atypical Hyperplasia/EIN

Case 3 - GYN. History: 66 year old, routine Pap test. Dr. Stelow

OMPRN Pathology Matters Meeting 2017

Clinicopathological Study of Associated Lesions in Benign Prostatic Hyperplasia and Prostatic Adenocarcinoma in Surgical Biopsy Specimens

Gleason grading and prognostic factors in carcinoma of the prostate

Rare prostate tumors: beyond adenocarcinoma

Updates in Urologic Pathology WHO Made Those Changes?! Peyman Tavassoli Pathology Department BC Cancer Agency

Prostate cancer staging and datasets: The Nitty-Gritty. What determines our pathological reports? 06/07/2018. Dan Berney Maastricht 2018

Kidney Case 1 SURGICAL PATHOLOGY REPORT

Muhammad Kashif Baig, Usman Hassan and Samina Mansoor

FINALIZED SEER SINQ QUESTIONS

STUDY OF PROSTATIC LESION FOR A PERIOD OF FIVE YEARS

Lung Tumor Cases: Common Problems and Helpful Hints

Page # 1. Endometrium. Cellular Components. Anatomical Regions. Management of SIL Thomas C. Wright, Jr. Most common diseases:

The 2015 World Health Organization Classification for Lung Adenocarcinomas: A Practical Approach

Endometrial Metaplasia, Hyperplasia & Other Cancer Mimics: a Consultant s Experience

Recommendations for the Reporting of Prostate Carcinoma

ADENOCARCINOMA OF THE PROSTATE

Kidney, Bladder and Prostate Neoplasia. David Bingham MD

1 NORMAL HISTOLOGY AND METAPLASIAS

Basement membrane in lobule.

Chapter 2. Understanding My Diagnosis

Diagnosis of prostate cancer

Gynecologic Cytopathology: Glandular lesions

Minimal Adenocarcinoma in Prostate Needle Biopsy Tissue

Salivary Glands 3/7/2017

Case #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ).

Papillary Lesions of the Breast A Practical Approach to Diagnosis. (Arch Pathol Lab Med. 2016;140: ; doi: /arpa.

Lesions Mimicking Adenoid Cystic Carcinoma. Diagnostic Problems in Salivary Gland Pathology An Update 5/29/2009

Neoplasias Quisticas del Páncreas

A re-audit of Prostate biopsies from January to December 2010 and 2013.

Epithelial tumors. Dr. F.F. Khuzin, PhD Dr. M.O. Mavlikeev

Case year old female presented with asymmetric enlargement of the left lobe of the thyroid

Case 4 Diagnosis 2/21/2011 TGB

Ground Glass Opacities

LYMPHATIC DRAINAGE AXILLARY (MOSTLY) INTERNAL MAMMARY SUPRACLAVICULAR

Original Article Collagenous micronodules in prostate cancer revisited: are they solely associated with Gleason pattern 3 adenocarcinomas?

G3.02 The malignant potential of the neoplasm should be recorded. CG3.02a

CLINICO PATHOLOGICAL STUDY OF ASSOCIATED LESIONS IN BENIGN PROSTATIC HYPERPLASIA AND PROSTATIC ADENOCARCINOMA IN SURGICAL BIOPSY SPECIMENS

2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a Pseudocapsule

B asal cell proliferations in the prostate gland exhibit a

The Hot Topic for today is a biopsy from a 58-year-old woman who had worrisome mammographic calcifications on screening.

Prostate Case Scenario 1

Morphological identification of the patterns of prostatic intraepithelial neoplasia and their importance

Oncocytic-Appearing Salivary Gland Tumors. Oncocytic, Cystic, Mucinous, and High Grade Salivary Gland Tumors SALIVARY GLAND FNA: PART II

Donald F. Gleason in 1966 created a unique grading system

ACCME/Disclosures. Case History 4/13/2016. USCAP GU Specialty Conference Case 3. Ann Arbor, MI

Metastatic Ductal Adenocarcinoma of the Prostate Cytologic Features and Clinical Findings

Transcription:

Prostate Pathology: Prostate Carcinoma, variants and Gleason Grading (Part 1) Jae Y. Ro, MD, PhD June 7, 2012

Ten Leading Cancer Types for the Estimated New Cancer Cases and Deaths By Sex, United States, 2012. CA Cancer J Clin 2012; 62(1):10-29

Cancers in Men, 2012 Incidence (41%) Prostate 241,740 29% 1 st Urinary Bladder 55,600 7% 4 th Kidney & renal pelvis 40,250 5% 6 th Estimated deaths (15%) Prostate 28,170 9% 2 nd Urinary Bladder 10,510 3% 8 th Kidney & renal pelvis 8,650 3% 10 th CA Cancer J Clin 2012;62 (1):10-29

Prostate Cancers Most frequently diagnosed cancer in men (total = 241,740; 29%) 2 nd cause of cancer mortality in men (total = 28,170; 9%) Reference: Siegel R et al: Cancer Statistics, 2012 CA Cancer J Clin 2012;62:10 29 American Cancer Society

Do your BeST! B represents Basic. e (effort) S represents Study. T represents Think. E represents Enjoy.

Do your BeST!

1. Basic Prostate anatomy Prostate histology

Disease of Prostate P. Zone (70%) T. Zone (5-10%) C. Zone (20%) CA (70%) CA (25%) CA (<5%) PIN BPH AAH BCH CCCH SA

2. Study Prostate cancers Microacinar carcinoma Gleason grading Variants Precancerous conditions Prostatic intraepithelial neoplasia Atypical adenomatous hyperplasia ASAP Stromal lesions

You have to look for 3 things! In biopsies, TURP and radical prostatectomies Small glands Medium/Large glands with atypia Stromal abnormalities

Prostate Carcinoma Well-diff. and poorly diff. adenocarcinoma well-diff. adenocarcinoma - For screening: three Too (too small, too crowded, and too clear) - For confirmation: nuclear enlargement, prominent nucleoli and lack of basal cells poorly diff. adenocarcinoma - Uniformity, p. nucleolus, no or low mitoses

Adenocarcinoma Other helpful features: Acid mucin Crystalloids Rigid luminal border Collagenous micronodules (mucinous fibroplasia) Glomerulation Perineural circumferential invasion Glands in fat

High grade prostatic carcinoma vs. Non-prostatic carcinoma Prostate Non-prostate N. monotony + - Nucleolus prominent variable Mitoses rare frequent

Gleason Grading, 1974

Pattern 1

Pattern 2

Pattern 3

Pattern 4

Pattern 5

Original, 1977 Revision, 2005

Gleason Grade, Revisited 2005 ISUP consensus (AJSP 29:1228, 2005) Gleason pattern 1, 2 (score 2-4 cancer) Cribriform form Isolated cells Variants of prostate cancers and special features seen in prostate cancers: Grading for variants of adenocarcinoma of prostate Vacuoles, collagenous micronodules, glomerulation

Gleason Grading, Revisited Original Gleason grade 1+1, most likely AAH (adenosis): Gleason score 1+1 should not be diagnosed in any specimens Gleason score 3-4: rarely seen in TURP, radical prostatectomy, and possibly biopsy from transition zone or at apex Gleason score 3-4 in needle biopsy should not make without consultation: 1) poor reproducibility, 2) poor correlation with prostatectomy, 3) misguide clinicians and patients into believing that the patient has an indolent cancer Possible very low-grade on needle biopsy: score 5 (2+3 or 3+2)

Gleason Grading, Revisited Cribriform Gleason pattern 2/3, most likely high grade PIN No cribriform pattern 2 cancers Cribriform 3, rounded, wellcircumscribed glands of similar size of normal glands (no basal cells) Individual cells are Gleason pattern 5, not allowed for Gleason pattern 3 Cribriform, new revision, 4 or 5

Cribriform pattern, 2011 2005 revision No pattern 2 May be pattern 3 2010-2011 revision No pattern 3 All pattern 4/5

No pattern 3, cribriform

Special features and variants of Ca (I) Vacuoles: can be seen in any patterns and should be distinguished from signet ring cell carcinoma Tumors should be graded, as if vacuoles were not present (by evaluating underlying architectural pattern) Adenoca with focal mucin extravasation: ignore mucin extravasation, grade based on the underlying architecture: distinguished from colloid (mucinous) carcinoma, Gleason score 4+4

Gleason Grading, Revisited Mucinous fibroplasia (collagenous micronodules) - Resembling cribriform structures - Subtract away mucinous fibroplasia, grade based on the underlying glandular architecture - Gleason score 3+3 Glomeruloid structures - Cribriform proliferation that is not transmural - Prognostic significance unknown - Lack of consensus, pattern 3 vs. 4 - Either approach is acceptable until future data

Variants of Prostate Ca Mucinous adenocarcinoma: Gleason pattern 4 may be 3 Ductal-endometrioid ca: 4 to 5 Sarcomatoid ca: 5 Signet ring cell ca: 5 LELC: 5 and oncocytic ca: 5 Foamy gland carcinoma: 3, may be higher Ca with atrophic & hyperplastic features: 3 Transition zone ca: 2 Small cell, TCC, squamous and adenosq ca: not be assigned GG

Original, 1974, 1977 Revision, 2005 New Revision, 2010, cribriform, 4 or 5

Gleason 3 vs. 4 Grade 3 Discrete units Can draw a circle around individual glands Presence of a few poorly formed glands under a high power is still O.K. for pattern 3 Grade 4 Fused glands Ill-defined papillary/cribriform glands solid nests with clear cells NOTE: any difficulty in small sample, conservative grading 3 is recommended

Mucinous Adenoca of Prostate Boyd first described a case of mucinous adenocarcinoma of the prostate in 1881 A rare variant of adenocarcinoma (Gleason pattern 4) Accounts for <0.5% of prostatic adenocarcinoma

Mucinous Adenoca of Prostate Criteria: At least 25% of total tumor volume Extracellular mucin pool with single or clusters of tumor cells floating in mucin lakes (nondilated glands containing mucin do not quality) Extraprostatic origin should be excluded: PSA and PAP positive in tumor cells

Mucinous Adenoca of Prostate In the past, most pathologists and clinicians believed 1) less aggressive 2) not likely to metastasize to bone 3) serum PSA and PAP not elevated 4) arose from female portion of gland Recent studies demonstrate as a variant of prostatic ca; prognosis not differ stage by stage

Mucinous Adenoca of Prostate Should exclude metastasis from other sites or direct extension Helpful features for 1st prostate mucinous ca. 1) Association with other histologic types of prostatic ca 2) Cuboidal or oval round tumor cells (not columnar) 3) Signet ring cells, goblet cells not present 4) Tumor cells floating in mucin lakes 5) PSA and PAP positivity in tumor cells.

Mucinous Adenoca of Prostate Age & symptoms not different from acinar carcinoma Elevated serum PSA & PAP LN and bone metastases with osteoblastic nature

Mucinous Adenoca of Prostate Mucin confined within glandular lumina should not be classified as mucinous carcinoma Mucinous areas occupy small portion of tumor designate as prostatic carcinoma with focal mucinous component (particularly in needle biopsies)

Intraluminal Acid Mucin Normal and benign glands usually contain neutral mucin Prostatic ca. contains neutral and acid mucins Intraluminal acid mucin in 70% of prostatic ca However, intracellular mucin not common in prostatic carcinoma Associated with intraluminal crystalloids Seen in benign conditions, such as SA Useful aids in diagnosing prostatic ca

Mucinous Adenoca of Prostate Management and Prognosis: Same as microacinar carcinoma (depends on clinical presentation and stage) Prognosis not different from other prostate carcinoma, stage by stage Neither grade of nonmucinous component nor proportion of mucinous component is associated with prognosis

Mucinous Adenoca of Prostate Differential Diagnosis Prostate Non-prostate Cells Cuboidal Columnar Goblet cells - + Signet ring cells - + Intracytoplasmic mucin Usually absent Present Immuno PSA, PAP + CEA + CK 20 - CK 20 +

Mucinous Adenoca of Prostate Summaries: A variant of prostatic carcinoma Accounts for < 0.5% of prostatic ca Symptoms, signs, Rx and prognosis not different from other prostatic ca Diagnostic criteria

Prostate Pathology: Prostate Carcinoma, variants and Gleason Grading (Part 2) Jae Y. Ro, MD, PhD June 7, 2012